Safety and tolerability of pirfenidone in asbestosis: a prospective multicenter study by Jelle R. Miedema, Catharina C. Moor, Marcel Veltkamp, Sara Baart, Natascha S. L. Lie, Jan C. Grutters, Marlies S. Wijsenbeek, Rémy L. M. Mostard

Get full text

Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosis. by Laura E M Eurelings, Jelle R Miedema, Virgil A S H Dalm, Paul L A van Daele, P Martin van Hagen, Jan A M van Laar, Willem A Dik

Get full text

Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients by Jelle R. Miedema, Matthijs L. Janssen, Matthijs L. Janssen, Jan von der Thüsen, Henrik Endeman, Anton W. Langerak, Merel E. Hellemons, Els van Nood, Bas W. A. Peeters, Sara J. Baart, Marco W. J. Schreurs

Get full text

The influence of green tea extract on nintedanib’s bioavailability in patients with pulmonary fibrosis by G.D.Marijn Veerman, Sanne C. van der Werff, Stijn L.W. Koolen, Jelle R. Miedema, Esther Oomen-de Hoop, Sophie C. van der Mark, Prewesh P. Chandoesing, Peter de Bruijn, Marlies S. Wijsenbeek, Ron H.J. Mathijssen

Get full text

Enhanced Bruton’s tyrosine kinase in B-cells and autoreactive IgA in patients with idiopathic pulmonary fibrosis by Peter Heukels, Jennifer A. C. van Hulst, Menno van Nimwegen, Carian E. Boorsma, Barbro N. Melgert, Jan H. von der Thusen, Bernt van den Blink, Rogier A. S. Hoek, Jelle R. Miedema, Stefan F. H. Neys, Odilia B. J. Corneth, Rudi W. Hendriks, Marlies S. Wijsenbeek, Mirjam Kool

Get full text